Suzanne Crowe - 05 Jun 2024 Form 4 Insider Report for AVITA Medical, Inc. (RCEL)

Role
Director
Signature
/s/ Donna Shiroma
Issuer symbol
RCEL
Transactions as of
05 Jun 2024
Net transactions value
$0
Form type
4
Filing time
06 Jun 2024, 19:36:12 UTC
Previous filing
08 Jun 2023
Next filing
29 Jan 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RCEL Common Stock Award +9,200 +34% 36,426 05 Jun 2024 Direct F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RCEL Stock Options (Right to Buy) Award $0 +3,943 $0.000000 3,943 05 Jun 2024 Common Stock 1 $9.51 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents an award of RSUs, each representing a contingent right to be issued one share of Common Stock, that are subject to time-based vesting criteria. These RSUs vest on the date 12 months following the grant date.
F2 Includes unvested RSUs.
F3 Includes 20,560 of the Issuer's CDIs. The Reporting Person's 20,560 CDIs translate into 4,112 of the shares of Common Stock set forth above.